ArticleERJ open research2022

Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist.

Toru Arai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.